NovoRapid

NovoRapid Use In Pregnancy & Lactation

insulin aspart

Manufacturer:

Novo Nordisk

Distributor:

DKSH
Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: NovoRapid (insulin aspart) can be used in pregnancy. Data from two randomised controlled clinical trials do not indicate any adverse effect of insulin aspart on pregnancy or on the health of the foetus/newborn when compared to soluble human insulin (see Pharmacology: Pharmacodynamics under Actions).
Intensified blood glucose control and monitoring of pregnant women with diabetes are recommended throughout pregnancy and when contemplating pregnancy. Insulin requirements usually fall in the first trimester and increase subsequently during the second and third trimesters. After delivery, insulin requirements normally return rapidly to pre-pregnancy values.
Lactation: There are no restrictions on treatment with NovoRapid during breast-feeding. Insulin treatment of the nursing mother presents no risk to the baby. However, the NovoRapid dosage may need to be adjusted.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in